Researcher
Philippe Selhorst
Affiliations
- Virology (Research unit)
Member
From1 Oct 2007 → Today
Projects
1 - 3 of 3
- Next-generation sequencing diagnostics to identify etiologies of acute undifferentiated fever in the Peruvian AmazonFrom1 May 2023 → Today
- Discovery of rodent-borne viruses over a biodiversity gradient in Morogoro, TanzaniaFrom1 Jan 2023 → 31 Dec 2023
- Clinical research platform for untargeted RNA virus detection in tropical fever patient populations: construction and applicationFrom1 Jan 2021 → Today
Publications
11 - 19 of 19
- Compartmentalization and clonal amplification of HIV-1 in the male genital tract characterized using next generation sequencing(2020)
Authors: Samuel Mundia Kariuki, P Selhorst, Colin Anthony, David Matten, Melissa-Rose Abrahams, Darren P Martin, Kevin Ariën, Kevin Rebe, Carolyn Williamson, Jeffrey R Dorfman
- Detectable HIV-1 in semen in individuals with very low blood viral loads(2020)
Authors: Samuel Mundia Kariuki, P Selhorst, Jennifer Norman, Karen Cohen, Kevin Rebe, Carolyn Williamson, Jeffrey R Dorfman
- A new genetic variant of dengue serotype 2 virus circulating in the Peruvian Amazon(2020)
Authors: Francesca Falconi Agapito, P Selhorst, Xiomara Merino, Fiorella Torres, J Michiels, Connie Fernandez, Michael Talledo, Kevin Ariën
Pages: 136-138 - M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding(2013)
Authors: P Selhorst, K. Grupping, T. Tong, E.T. Crooks, L. Martin, G Vanham, J.M. Binley, Kevin Ariën
Pages: 1-9 - In vitro activity of candidate microbicides against cell-associated HIV(2012)
Authors: P Selhorst, K. Grupping, T Bourlet, O Delezay, Kevin Ariën, G Vanham
Pages: 805-815 - MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency(2012)
Authors: K. Grupping, P Selhorst, J Michiels, K Vereecken, L Heyndrickx, P. Kessler, G Vanham, L. Martin, Kevin Ariën
Pages: 1-16 - Human Immunodeficiency Virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides(2011)
Authors: P Selhorst, AC Vazquez, K Terrazas-Aranda, J Michiels, K Vereecken, L Heyndrickx, J Weber, ME Quiñones-Mateu, Kevin Ariën, G Vanham
Pages: 1403-1413 - Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference(2010)
Authors: B. Wahren, P. Biswas, M. Borggren, A Coleman, K Da Costa, W De Haes, T Dieltjens, S Dispinseri, K Grupping, D Hallengard, et al.
Pages: 71 - Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-importance of slow dissociation and relaxation rates for antiviral efficacy(2010)
Authors: M Elinder, P Selhorst, G Vanham, B Oberg, L Vrang, UH Danielson
Pages: 1133-1140